-
Je něco špatně v tomto záznamu ?
Advanced glycoxidation end products in chronic diseases-clinical chemistry and genetic background
Kalousová M., Zima T., Tesař V., Dusilová-Sulková S., Škrha J.
Jazyk angličtina Země Nizozemsko
- MeSH
- chronická nemoc MeSH
- chronické selhání ledvin komplikace metabolismus MeSH
- diabetes mellitus genetika metabolismus MeSH
- financování organizované MeSH
- klinická chemie metody MeSH
- laktoylglutathionlyasa genetika metabolismus MeSH
- lidé MeSH
- mitogenem aktivované proteinkinasy genetika metabolismus MeSH
- nukleotidy metabolismus MeSH
- oxidace-redukce MeSH
- oxidační stres MeSH
- polymorfismus genetický MeSH
- produkty pokročilé glykace analýza metabolismus MeSH
- receptory cytoplazmatické a nukleární metabolismus MeSH
- zánět etiologie MeSH
- Check Tag
- lidé MeSH
Several diseases (atherosclerosis, diabetes mellitus, chronic renal failure) are associated with oxidative and carbonyl stress, microinflammation and eventually autoimmune reaction. Both oxidative and carbonyl stress cause damage to important biological structures-proteins, carbohydrates, lipids and nucleic acids and may enhance inflammatory response. New compounds and modified structures are formed, among them advanced oxidation protein products (AOPP), advanced glycation end products (AGEs-e.g. pentosidine, carboxymethyllysine) and advanced lipoperoxidation end products (ALEs). Accumulation of glycoxidation products, upregulation of protective mechanisms like glyoxalase I as well as enhanced transcription of genes coding for cytokines, growth factors and adhesive molecules via AGE-RAGE (receptor for AGEs) interaction and subsequent increase of classical acute phase reactants (e.g. CRP-C-reactive protein or orosomucoid) can be observed in a variety of chronic diseases. Additionally, several RAGE gene polymorphisms have shown association with some pathological states-diabetic complications, vascular damage, inflammatory response or antioxidant status. Recent advances in understanding the pathogenesis of chronic diseases provide new possibilities for diagnostics and monitoring of severely ill patients, however, further studies are still required to establish efficient therapeutical strategies.
- 000
- 03915naa 2200505 a 4500
- 001
- bmc07507100
- 003
- CZ-PrNML
- 005
- 20120118090216.0
- 008
- 080729s2005 ne e eng||
- 009
- AR
- 040 __
- $a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Kalousová, Marta, $d 1974- $7 mzk2005318016
- 245 10
- $a Advanced glycoxidation end products in chronic diseases-clinical chemistry and genetic background / $c Kalousová M., Zima T., Tesař V., Dusilová-Sulková S., Škrha J.
- 314 __
- $a Institute of Clinical Chemistry and Laboratory Diagnostics, First Faculty of Medicine and General University Hospital, Charles University, Katerinská 32, 12108 Prague 2, Czech Republic. marta.kalousova@seznam.cz
- 520 9_
- $a Several diseases (atherosclerosis, diabetes mellitus, chronic renal failure) are associated with oxidative and carbonyl stress, microinflammation and eventually autoimmune reaction. Both oxidative and carbonyl stress cause damage to important biological structures-proteins, carbohydrates, lipids and nucleic acids and may enhance inflammatory response. New compounds and modified structures are formed, among them advanced oxidation protein products (AOPP), advanced glycation end products (AGEs-e.g. pentosidine, carboxymethyllysine) and advanced lipoperoxidation end products (ALEs). Accumulation of glycoxidation products, upregulation of protective mechanisms like glyoxalase I as well as enhanced transcription of genes coding for cytokines, growth factors and adhesive molecules via AGE-RAGE (receptor for AGEs) interaction and subsequent increase of classical acute phase reactants (e.g. CRP-C-reactive protein or orosomucoid) can be observed in a variety of chronic diseases. Additionally, several RAGE gene polymorphisms have shown association with some pathological states-diabetic complications, vascular damage, inflammatory response or antioxidant status. Recent advances in understanding the pathogenesis of chronic diseases provide new possibilities for diagnostics and monitoring of severely ill patients, however, further studies are still required to establish efficient therapeutical strategies.
- 650 _2
- $a klinická chemie $x metody $7 D002624
- 650 _2
- $a chronická nemoc $7 D002908
- 650 _2
- $a produkty pokročilé glykace $x analýza $x metabolismus $7 D017127
- 650 _2
- $a mitogenem aktivované proteinkinasy $x genetika $x metabolismus $7 D020928
- 650 _2
- $a diabetes mellitus $x genetika $x metabolismus $7 D003920
- 650 _2
- $a zánět $x etiologie $7 D007249
- 650 _2
- $a chronické selhání ledvin $x komplikace $x metabolismus $7 D007676
- 650 _2
- $a laktoylglutathionlyasa $x genetika $x metabolismus $7 D007791
- 650 _2
- $a nukleotidy $x metabolismus $7 D009711
- 650 _2
- $a oxidace-redukce $7 D010084
- 650 _2
- $a oxidační stres $7 D018384
- 650 _2
- $a polymorfismus genetický $7 D011110
- 650 _2
- $a receptory cytoplazmatické a nukleární $x metabolismus $7 D018160
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a financování organizované $7 D005381
- 700 1_
- $a Zima, Tomáš, $d 1966- $7 jn20000620440
- 700 1_
- $a Tesař, Vladimír, $d 1957- $7 jn20000402349
- 700 1_
- $a Sulková, Sylvie, $d 1954- $7 jn20000710614
- 700 1_
- $a Škrha, Jan, $d 1954- $7 jn99240001641
- 773 0_
- $w MED00003430 $t Mutation research. [All sections] $g Roč. 579, č. 1-2 (2005), s. 37-46 $x 0027-5107
- 910 __
- $a ABA008 $b B 1575 $y 9
- 990 __
- $a 20080721085927 $b ABA008
- 991 __
- $a 20120118090203 $b ABA008
- 999 __
- $a ok $b bmc $g 622708 $s 475141
- BAS __
- $a 3
- BMC __
- $a 2005 $b 579 $c 1-2 $d 37-46 $i 0027-5107 $m Mutation research $x MED00003430
- LZP __
- $a 2008-Doreen